Abaloparatide

Category: Osteoporosis



Abaloparatide Overview

Abaloparatide (brand name Tymlos; formerly BA058) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent.[1] On 28 April 2017, it was approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis. Contents 1 Therapeutics 1.1 Medical use 1.2 Dosage 1.3 Warnings and Precautions 1.4 Side Effects 2 Pharmaco...

Read more Abaloparatide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abaloparatide

Recent Abaloparatide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abaloparatide
  • Solution: 3.12mg/1.56ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Abaloparatide or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA